Good luck getting a table without a $900 Amex.
We dive into some data.
Hint: it has to do with data sovereignty.
“Quickly became the only newsletter I open every morning. I like that I know what’s going on, but don’t feel terrible after I finish reading.” -Amy, reader since 2022
Another major Canadian IPO could be on the horizon.
Mythos is causing some more drama.
What's old is new again.
Live on the ground at the Eurasia Group’s U.S.-Canada Summit.
We asked and found out.
Why is the DRC’s Ebola outbreak so alarming?
And can film play a role in Canadian sovereignty?
What, if anything, can we learn from the complicated track record of Milei’s radical economic experiment?
Talk about shooting for the stars.
A little risk never hurt anyone (really).
Gen Z is getting hooked.
Say hello to the Gordie Howe International Bridge.
Quick Q&As with Canadians doing interesting things.
A Q&A with the restaurateur behind some of Toronto's top dining rooms.
A Q&A with the Canada Soccer CEO.
Life sciences investing, innovation in cancer treatment, and opportunities in Canada's biotech sector.